Brought to you by

May 19, 2014 Issue:

Recent Health Care M&A Deals

Medical Devices






Boston Scientific Corp.

Bayer Interventional div.

$415 million




Akorn, Inc.

VersaPharm Incorporated

$440 million

Santen Pharmaceutical Co.

Merck ophthalmology assets

$600 million

Pernix Therapeutics

U.S. rights to Treximet®

$250 million

Physician Medical Groups



IPC The Hospitalist Company

RG Psychological Services


Technology Deal of the Week
Boston Scientific Corp. (NYSE: BSX) is on a roll this month. On May 6, the company acquired IoGyn, Inc., a California startup focused on products used in gynecological surgery, for $65 million. Last week it announced a larger transaction, paying $415 million in cash for Bayer Interventional division (XETRA: BAYN), based in Minneapolis, Minnesota. Bayer Interventional offers technologies to treat coronary and peripheral vascular disease, and it will be tucked into Boston Scientific’s Peripheral Interventions business. Last year, BSX made only one acquisition (publicly announced), the $275 million purchase of Bard EP (NYSE: BCR) for $275 million………Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Charted Territory
While most of the media is focused on Pfizer’s (NYSE: PFE) bid for AstraZeneca (NYSE: AZN), Merck & Co. (NYSE: MRK) has been selling assets like it’s going out of business. Just this year, it has raked in $15 billion, thanks largely to the $14.2 billion sale of its OTC business to Bayer AG (XETRA: BAYN), announced this month. Since 2002, we’ve captured a total of 27 deals for Merck assets, including the rights to various drugs or compounds, totally about $17.6 billion. By contrast, Merck has paid more than $53 billion for other companies and compounds, since 2000. And several of those deals came without prices, such as its sole 2014 acquisition of NanoBio’s nanoemulsion technology. We’re expecting something bigger from Merck, coming soon. Stay tuned. 
Merck & Co. Divestitures, 2009 to 2014        


Merck & Co. business



Santen Pharmaceutical Co.

Ophthalmology assets

$600 million

May 13, 2014

KBI Biopharma, Inc.

Microbial operations


May 13, 2014

Bayer AG

OTC business

$14.2 billion

May 6, 2014

Alnylam Pharmaceuticals

Sirna Therapeutics, Inc.

$175 million

Jan. 12, 2014

Aspen Group

API business

$1.0 billion

June 27, 2013

Johnson & Johnson, Inc.

Stake in OTC business

$175 million

Sept. 28, 2011

FujiFilm Holdings

BioManufacturing Network

$490 million

Feb. 27, 2011

Covance, Inc.

Gene expression laboratory

$9.75 million

July 29, 2009

Microsoft Corporation

Rosetts Biosoftware


June 1, 2009

Source: The Health Care M&A News, May 2014
Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today
Services Deal of the Week
It’s not a done deal, but last week Kindred Healthcare (NYSE: KND) launched a hostile takeover of Gentiva Health Services (NASDAQ: GTIV). The offer includes a combination of $7 per share in cash plus $7 in KND stock for each share of Gentiva, valued at approximately $533 million, and assumption of Gentiva’s debt, which brings the total to $1.6 billion. Kindred made its pursuit public after Gentiva rejected its overtures, noting that its offer represents a 64% premium to GTIV’s May 14 closing price, and 8.9x 2014E EBITDA. Gentiva, a home health care company, made one acquisition last year, buying Harden Healthcare Holdings for $409 million.  Kindred, on the other hand, made nine acquisitions in 2013, five of them privately held home health care companies (so no prices were disclosed)…….Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
In the Pipeline
New York City-based Flatiron Health, which developed the OncologyCloud™ platform, raised $130 million for its Series B round, led by Google Ventures, with participation from existing investors First Round Capital and Laboratory Corporation of America Holdings. At the same time, Flatiron agreed to acquire Altos Solutions, Inc., a leading web-based oncology software company and developer of the OncoEMR® system, for an undisclosed price. The two companies expect to finalize the transaction by the end of May 2014……..Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Sponsored Content:
Venture Capital Investing Conference 2014: June 10-11
Venture 2014 serves as the celebration of the IBF 25th Annual Venture Capital Investing Conference, offering investment forecasts, best practices, and experiences from a cross-section of venture investors. Uncovering what the future holds for our industry, attendees take home unparalleled value in quality of program, which focuses on the information gap between venture capitalists and institutional investors, concentrated networking opportunities for syndication and fundraising, and the latest perspectives on trends and best practices for the industry as a whole. Click here for more information.
ACG Chicago’s 5th Annual Healthcare M&A Conference
The 5th Annual Healthcare M&A Conference on June 17 will bring 300+ professionals together at the Hyatt Regency Chicago. This gathering of corporate & private equity executives, investors, lenders, investment bankers & national experts features a day of thought provoking sessions followed by an ACG Capital Connection reception. Over 50 firms share their experience and expertise, or exhibit. Visit for more information and register to join us for this unparalleled access to healthcare M&A.
mHealth + Telehealth World 2014
mHealth + Telehealth World 2014 taking place July 22 – 24, 2014 in Boston, MA brings together hospitals, health systems, health plans, and innovators to share successes and failures of existing programs and discover new technologies and strategies for expansion of programs. Network with experts in mHealth and Telehealth as you learn valuable strategies to bring success to your organization. We are happy to extend a $300 registration discount to you when you mention promo code HCM&A. For more information or to register, please visit or call 800.767.9499.
Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Conference Partnerships… Click here to see more